Center for Scientific Review; Notice of Closed Meetings, 659 [2013-31494]
Download as PDF
<![CDATA[
Federal Register / Vol. 79, No. 3 / Monday, January 6, 2014 / Notices
for accessibility reasons, or if you have
any questions, contact Dale L. Aultman,
Secretary to the Farm Credit
Administration Board, at (703) 883–
4009. The matters to be considered at
the meeting are:
Open Session
A. Approval of Minutes
• December 12, 2013
B. New Business
• Standards of Conduct—Proposed
Rule
C. Reports
• Equal Employment Opportunity
and Inclusion Update
• Auditor’s Report on FCA FY 2013/
2012 Financial Statements
Closed Session *
• Executive Meeting with Auditors
Dated: January 2, 2014.
Dale L. Aultman,
Secretary, Farm Credit Administration Board
[FR Doc. 2014–00024 Filed 1–2–14; 4:15 pm]
BILLING CODE 6705–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
mstockstill on DSK4VPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Program
Project: Pain and Drug Abuse.
Date: January 22–23, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: John Bishop, Ph.D.,
Scientific Review Officer, Center for
* Session Closed-Exempt pursuant to 5 U.S.C.
Section 552b(c)(2).
VerDate Mar<15>2010
17:08 Jan 03, 2014
Jkt 232001
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5182,
MSC 7844, Bethesda, MD 20892, (301) 408–
9664, bishopj@csr.nih.gov.
Name of Committee: Cardiovascular and
Respiratory Sciences Integrated Review
Group Lung Injury, Repair, and Remodeling
Study Section.
Date: February 3–4, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW.,
Washington, DC 20015.
Contact Person: Ghenima Dirami, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4122,
MSC 7814, Bethesda, MD 20892, 240–498–
7546, diramig@csr.nih.gov.
Name of Committee: Musculoskeletal, Oral
and Skin Sciences Integrated Review Group
Arthritis, Connective Tissue and Skin Study
Section.
Date: February 3–4, 2014.
Time: 8:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Garden Inn, 7301 Waverly
Street, Bethesda, MD 20814.
Contact Person: Aftab A. Ansari, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4108,
MSC 7814, Bethesda, MD 20892, 301–237–
9931, ansaria@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: December 30, 2013.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–31494 Filed 1–3–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Fiscal Year (FY) 2014 Funding
Opportunity
Substance Abuse and Mental
Health Services Administration, HHS.
ACTION: Notice of intent to award a
single source grant to the National
Association of State Alcohol and Drug
Abuse Directors (NASADAD).
AGENCY:
SUMMARY: This notice is to inform the
public that the Substance Abuse and
Mental Health Services Administration
(SAMHSA) intends to award $1.162
million (total costs) for up to three years
to NASADAD for Technical Assistance
PO 00000
Frm 00027
Fmt 4703
Sfmt 4703
659
to States for Implementation of the
Substance Abuse Block Grant (SABG)
for Prevention and Treatment (Short
Title: SABG–TA). The purpose of this
program is to provide technical
assistance (TA) to substance abuse
Single State Agencies (SSAs) to increase
service capacity, including recovery
support services, develop integrated
systems of care, improve behavioral
health outcomes, and support strategies
for addressing health disparities in use
of the National Standards for Culturally
and Linguistically Appropriate Services
(CLAS) in Health and Health Care. In
addition, the program will provide TA
support to the National Prevention
Network (NPN) leadership in support of
the further development of state
prevention systems as it relates to the
implementation of the SABG program.
SABG–TA funds will be used to assist
states in responding to emerging issues,
such as the Affordable Care Act, parity,
information technology innovations,
implementation of evidence-based
practices, and issues related to program
integrity. These funds are used for
prevention, treatment, recovery support,
and other services that will assist in the
development, implementation, and
management of the SABG program.
Funding Opportunity Title: TI–14–
002.
Catalog of Federal Domestic
Assistance (CFDA) Number: 93.243.
Authority: Section 1935 of the Public
Health Services Act, as amended.
Justification: Eligibility for this award
is limited to NASADAD. NASADAD is
in the unique position to facilitate these
activities because:
• NASADAD is the sole and unique
organization with a direct official
relationship with the SSAs and is the
only agency of its type representing all
the SSAs for substance use disorder
treatment and primary prevention
activities.
• NASADAD has helped to
professionalize the field, and support
the systematic development of
evidence-based models of screening,
assessment, treatment, and recovery
support services. Such interventions
yield favorable outcomes, are costeffective, scalable, and sustainable.
Significant investments in training and
workforce development have made
these interventions accessible to
providers of treatment and prevention
services around the country.
• Over the years, NASADAD has built
an extensive array of constituency
groups and has maintained these
ongoing memberships in order to
coordinate group activities via
teleconference, net conference, or in
person meetings, as necessary for the
E:\FR\FM\06JAN1.SGM
06JAN1
]]>Agencies
[Federal Register Volume 79, Number 3 (Monday, January 6, 2014)]
[Notices]
[Page 659]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-31494]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel Program Project: Pain and Drug Abuse.
Date: January 22-23, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: John Bishop, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5182, MSC 7844, Bethesda, MD 20892, (301) 408-
9664, bishopj@csr.nih.gov.
Name of Committee: Cardiovascular and Respiratory Sciences
Integrated Review Group Lung Injury, Repair, and Remodeling Study
Section.
Date: February 3-4, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Road NW., Washington, DC 20015.
Contact Person: Ghenima Dirami, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4122, MSC 7814, Bethesda, MD
20892, 240-498-7546, diramig@csr.nih.gov.
Name of Committee: Musculoskeletal, Oral and Skin Sciences
Integrated Review Group Arthritis, Connective Tissue and Skin Study
Section.
Date: February 3-4, 2014.
Time: 8:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Garden Inn, 7301 Waverly Street, Bethesda, MD
20814.
Contact Person: Aftab A. Ansari, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4108, MSC 7814, Bethesda, MD
20892, 301-237-9931, ansaria@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: December 30, 2013.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-31494 Filed 1-3-14; 8:45 am]
BILLING CODE 4140-01-P
